ANDERA PARTNERS

Position in IVA — Inventiva S.A.

CIK 1757283 PARIS, I0

Position in IVA

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$10,090,904

+$1,636,363 QoQ

Shares Held

1,818,181

0.0% QoQ

Ownership

0.770%

of shares outstanding

% of Portfolio

5.70%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ANDERA PARTNERS holds $121,676,488 across 5 Biotechnology names. IVA ranks #4 (8.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc.	1,897,362	$43,620,352
2	MLYS	Mineralys Therapeutics, Inc.	1,591,917	$43,125,031
3	AGMB	Agomab Therapeutics NV	1,538,702	$16,140,983
4	IVA	Inventiva S.A. This page	1,818,181	$10,090,904
5	ABVX	Abivax S.A.	78,125	$8,699,218

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,090,904	1,818,181	-87.1%	Shares	Sole	2026-05-11
2025-12-31	$65,632,313	14,114,476	+676.3%	Shares	Sole	2026-02-17
2025-12-31	$8,454,541	1,818,181	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.